Imunon Inc IMNN:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
1.67quote price arrow down-0.01 (-0.89%)
Volume
25,267
52 week range
1.54 - 15.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.67
  • 52 Week High15.75
  • 52 Week High Date10/14/21
  • 52 Week Low1.54
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap11.82M
  • Shares Out7.10M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.20
  • YTD % Change-79.44

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.67
  • 52 Week High15.75
  • 52 Week High Date10/14/21
  • 52 Week Low1.54
  • 52 Week Low Date09/26/22
  • Market Cap11.82M
  • Shares Out7.10M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.20
  • YTD % Change-79.44

RATIOS/PROFITABILITY

  • EPS (TTM)-4.35
  • P/E (TTM)-0.38
  • Fwd P/E (NTM)-1.02
  • EBITDA (TTM)-21.712M
  • ROE (TTM)-47.07%
  • Revenue (TTM)500,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,229.82%
  • Debt To Equity (MRQ)12.64%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Imunon Inc

 

Profile

MORE
Imunon, Inc., formerly Celsion Corporation, is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments, including deoxyribonucleic acid (DNA)-based immunotherapies, vaccines and directed chemotherapies through clinical trials. Its lead clinical program GEN-1, a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer. GEN-1 works by instructing the body to produce cancer-fighting molecules, such as...
Michael Tardugno
Executive Chairman of the Bpard
Corinne Le Goff Pharm.D.
President, Chief Executive Officer, Director
Jeffrey Church CPA
Chief Financial Officer, Executive Vice President
Khursheed Anwer Ph.D.
Executive Vice President, Chief Scientific Officer
Nicholas Borys M.D.
Executive Vice President, Chief Medical Officer
Address
997 Lenox Dr Ste 100
Lawrence Township, NJ
08648-2317
United States

Top Peers

SYMBOLLASTCHG%CHG
VBLT
Vascular Biogenics Ltd
0.17+0.0098+6.12%
BLCM
Bellicum Pharmaceuticals Inc
1.17-0.04-3.33%
HOTH
Hoth Therapeutics Inc
0.3384+0.0109+3.33%
NEXI
Neximmune Inc
0.635+0.0562+9.71%
NBSE
NeuBase Therapeutics Inc
0.399+0.003+0.76%